Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolfgang

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Physics in Medicine and Biology|August 18, 2021
Toward MR-integrated proton therapy: modeling the potential benefits for liver tumorsMaryam Moteabbed, Julien Smeets, Theodore S Hong, et al.
The Journal of Surgical Research|July 20, 2002
Protein kinase C activation of intestinal glutamine transport is mediated by mitogen-activated protein kinasesMing Pan, Christopher A Wolfgang, Anne M Karinch, et al.
European Journal of Pharmacology|February 11, 1994
Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptorsJ W Constantine, W S Lebel, H A Woody, et al.
Acta Odontologica Scandinavica|December 1, 1988
19F MAS-NMR and solution chemical characterization of the reactions of fluoride with hydroxyapatite and powdered enamelD J White, W D Bowman, R V Faller, et al.
Medical Physics|April 14, 2010
Variations in tumor size and position due to irregular breathing in 4D-CT: a simulation studyJoyatee Sarker, Alan Chu, Kit Mui, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolismHeike Kölsch, Dieter Lütjohann, Frank Jessen, et al.
Practical Radiation Oncology|November 25, 2015
Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trialJoshua R Niska, Florence K Keane, John A Wolfgang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Design of 4D treatment planning target volumesEike Rietzel, Arthur K Liu, Karen P Doppke, et al.
The Journal of Biological Chemistry|May 20, 1994
Peptide substrate cleavage specificity of the human cytomegalovirus proteaseV V Sardana, J A Wolfgang, C A Veloski, et al.
Practical Radiation Oncology|March 26, 2017
Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?Shyam K Tanguturi, Andrzej Niemierko, Jennifer Y Wo, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Physics in Medicine and Biology|August 18, 2021
Toward MR-integrated proton therapy: modeling the potential benefits for liver tumorsMaryam Moteabbed, Julien Smeets, Theodore S Hong, et al.
The Journal of Surgical Research|July 20, 2002
Protein kinase C activation of intestinal glutamine transport is mediated by mitogen-activated protein kinasesMing Pan, Christopher A Wolfgang, Anne M Karinch, et al.
European Journal of Pharmacology|February 11, 1994
Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptorsJ W Constantine, W S Lebel, H A Woody, et al.
Acta Odontologica Scandinavica|December 1, 1988
19F MAS-NMR and solution chemical characterization of the reactions of fluoride with hydroxyapatite and powdered enamelD J White, W D Bowman, R V Faller, et al.
Medical Physics|April 14, 2010
Variations in tumor size and position due to irregular breathing in 4D-CT: a simulation studyJoyatee Sarker, Alan Chu, Kit Mui, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolismHeike Kölsch, Dieter Lütjohann, Frank Jessen, et al.
Practical Radiation Oncology|November 25, 2015
Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trialJoshua R Niska, Florence K Keane, John A Wolfgang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2006
Design of 4D treatment planning target volumesEike Rietzel, Arthur K Liu, Karen P Doppke, et al.
The Journal of Biological Chemistry|May 20, 1994
Peptide substrate cleavage specificity of the human cytomegalovirus proteaseV V Sardana, J A Wolfgang, C A Veloski, et al.
Practical Radiation Oncology|March 26, 2017
Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?Shyam K Tanguturi, Andrzej Niemierko, Jennifer Y Wo, et al.
Pageof 4